Skip to main content
SpringerLink
Log in

Renal Cancer: Surgical Management

  • Chapter
  • First Online:
Urological Oncology

  • 1624 Accesses

Abstract

For many years treatment the for renal cancer (RC) has been synonymous with nephrectomy. With the trend of presentation changing, early diagnosis of renal cancer has led to evolution of newer nephron-sparing approaches. Similarly, with understanding of molecular biology, innovative drug treatments have taken a prime role in metastatic renal cancer. This chapter deals with the surgical principles in the management of RC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ljungberg B, Bensalah K, Bex A, et al (April 2014) Guidelines on Renal Cell Carcinoma, Available at: http://www.uroweb.org/gls/pdf/10%20Renal%20Cell%20Carcinoma_LR.pdf (Accessed: 10th September 2014).

  3. Simmons MN, Weight CJ, Gill IS. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes. Urology. 2009;73:1077–82.

    Article  PubMed  Google Scholar 

  4. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179:468–71.

    Article  PubMed  Google Scholar 

  5. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001;166:6–18.

    Article  CAS  PubMed  Google Scholar 

  6. Aron M, Haber G-P, Gill IS. Laparoscopic partial nephrectomy: ready for prime time. Eur Urol (Suppl). 2006;5:968–74.

    Article  Google Scholar 

  7. Becker F, Van Poppel H, Hakenberg OW, et al. Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol. 2009;56:625–35.

    Article  PubMed  Google Scholar 

  8. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805.

    Article  CAS  PubMed  Google Scholar 

  9. Henriksen JH, Petersen HK. Renal blood flow and metabolism after cold ischaemia: peroperative measurements in patients with calculi. Clin Physiol. 1984;4:41–50.

    Article  CAS  PubMed  Google Scholar 

  10. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45:673–6.

    Article  CAS  PubMed  Google Scholar 

  11. Pasupathy S, Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surg. 2005;29:106–15.

    Article  CAS  PubMed  Google Scholar 

  12. Brasile L, Green E, Haisch C. Warm ex vivo perfusion prevents reperfusion injury in warm ischemically damaged kidneys. Transplant Proc. 1997;29:3422–3.

    Article  CAS  PubMed  Google Scholar 

  13. Wu SD, Viprakasit DP, Cashy J, et al. Radiofrequency ablation-assisted robotic laparoscopic partial nephrectomy without renal hilar vessel clamping versus laparoscopic partial nephrectomy: a comparison of perioperative outcomes. J Endourol. 2010;24:385–91.

    Article  PubMed  Google Scholar 

  14. Patel HD, Pierorazio PM, Mullins JK, Hyams ES, Allaf ME. Radiofrequency coagulation-assisted laparoscopic partial nephrectomy without hilar clamping: a feasible technique with excellent outcomes in highly selected patients. J Endourol. 2012;26(1):58–62.

    Article  PubMed  Google Scholar 

  15. Gong EM, Orvieto MA, Zorn KC, Lucioni A, Steinberg GD, Shalhav AL. Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol. 2008;22:953–7.

    Article  PubMed  Google Scholar 

  16. Lane BR, Gill IS. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol. 2010;183:473–9.

    Article  PubMed  Google Scholar 

  17. Godoy G, Ramanathan V, Kanofsky JA, et al. Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate. J Urol. 2009;181:2438–43.

    Article  PubMed  Google Scholar 

  18. Van Haute W, Gavazzi A, Dasgupta P. Current status of robotic partial nephrectomy. Curr Opin Urol. 2010;20:371–4.

    Article  PubMed  Google Scholar 

  19. White MA, Haber GP, Autorino R, et al. Outcomes of robotic partial nephrectomy for renal masses with nephrometry score of ≥ 7. Urology. 2011;77:809–13.

    Article  PubMed  Google Scholar 

  20. Simhan J, Smaldone MC, Tsai KJ, et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol. 2011;60:724–30.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Pareek G, Hedican SP, Gee JR, et al. Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques. J Urol. 2006;175:1208–13.

    Article  PubMed  Google Scholar 

  22. Lane BR, Novick AC, Babineau D, et al. Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179:847–51.

    Article  PubMed  Google Scholar 

  23. Portis AJ, Yan Y, Landman J, et al. Long-term follow up after laparoscopic radical nephrectomy. J Urol. 2002;167:1257–62.

    Article  PubMed  Google Scholar 

  24. Novick A, Campbell S, Belldegrun A, et al (2010) Guideline for Management of the Clinical Stage 1 Renal Mass, Available at: https://www.auanet.org/education/guidelines/renal-mass.cfm (Accessed: 10th September 2014).

  25. Jewett MAS, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60:39–44.

    Article  PubMed  Google Scholar 

  26. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.

    Article  PubMed  Google Scholar 

  27. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331–4.

    Article  PubMed  Google Scholar 

  28. Karellas ME, Jang TL, Kagiwada MA, et al. Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection. BJU Int. 2009;103:160–4.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Assouad J, Riquet M, Foucault C, et al. Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology. 2006;39:3926–32.

    Google Scholar 

  30. Capitanio U, Jeldres C, Patard JJ, et al. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int. 2009;103:33–7.

    Article  PubMed  Google Scholar 

  31. Blute ML, Leibovich BC, Cheville JC, et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol. 2004;172:465–9.

    Article  PubMed  Google Scholar 

  32. Hutterer GC, Patard JJ, Perrotte P, et al. Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Inter J Cancer. 2007;121:2556–61.

    Article  CAS  Google Scholar 

  33. Blom JHM, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55:28–34.

    Article  PubMed  Google Scholar 

  34. Campbell SC, Lane BR. Chapter 49. Malignant renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell Walsh urology, vol. II. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1413–75.

    Chapter  Google Scholar 

  35. Haferkamp A, Bastian PJ, Jakobi H, et al. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term follow up. J Urol. 2007;177:1703–8.

    Article  PubMed  Google Scholar 

  36. Wszolek MF, Wotkowicz C, Libertino JA. Surgical management of large renal tumors. Nat Clin Pract Urol. 2008;5:35–46.

    Article  PubMed  Google Scholar 

  37. Moinzadeh A, Libertino JA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol. 2004;171:598–601.

    Article  PubMed  Google Scholar 

  38. Sohaib SA, Teh J, Nargund VH, Lumley JS, et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol. 2002;167(3):1271–5.

    Article  Google Scholar 

  39. Montie JE, el Ammar R, Pontes JE, et al. Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet. 1991;173:107–15.

    CAS  PubMed  Google Scholar 

  40. Boorjian SA, Sengupta S, Blute ML. Renal cell carcinoma: vena cava involvement. BJU Int. 2007;99:1239–44.

    Article  PubMed  Google Scholar 

  41. Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94:33–41.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Barts and The Royal London Hospital, London, UK

    Adam Alleemudder MBChB, BSc, MRCs

  2. Department of Urology, Homerton University Hospital, London, UK

    Vinod H. Nargund

Authors
  1. Adam Alleemudder MBChB, BSc, MRCs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinod H. Nargund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam Alleemudder MBChB, BSc, MRCs .

Editor information

Editors and Affiliations

  1. Department of Urology, Homerton University Hospital & Formerly St. Bartholomew's Hospital, London, United Kingdom

    Vinod H. Nargund

  2. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA

    Derek Raghavan

  3. Radiation Oncology, Cedars Sinai Cancer Center, Los Angeles, California, USA

    Howard M. Sandler

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Alleemudder, A., Nargund, V.H. (2015). Renal Cancer: Surgical Management. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-482-1_22

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-481-4

  • Online ISBN: 978-0-85729-482-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation